Results 151 to 160 of about 9,615 (165)
Some of the next articles are maybe not open access.
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
New England Journal of Medicine, 2019Jacqueline Barrientos +2 more
exaly
Cardiovascular Toxicities Associated With Ibrutinib
Journal of the American College of Cardiology, 2019Javid J. Moslehi +2 more
exaly
Ibrutinib Regimens Versus Chemoimmunotherapy in Older Patients With Untreated CLL
New England Journal of Medicine, 2018Kerry Rogers +2 more
exaly
Phase 3 Trial of Ibrutinib Plus Rituximab in Waldenström’s Macroglobulinemia
New England Journal of Medicine, 2018Steven P. Treon +2 more
exaly
Ibrutinib and Venetoclax for First-Line Treatment of CLL
New England Journal of Medicine, 2019Keyur P Patel +2 more
exaly
Ibrutinib Plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
New England Journal of Medicine, 2018Sasanka M Handunnetti +2 more
exaly
Ibrutinib for the Treatment of Bing-Neel Syndrome: A Multicenter Study
Blood, 2019Maria Lia Palomba +2 more
exaly

